Urinary Leukotriene E4
Overview
Authors
Affiliations
Measurement of urinary leukotriene E4 (LTE4) is a sensitive and noninvasive method of assaying total body cysteinyl leukotriene production and changes in cysteinyl leukotriene levels in specific microenvironments, such as the airway. Urinary LTE4 measurements can be used as sensitive biomarkers of exposure to asthma triggers, such as air pollution and viral infections. Recent studies suggest the potential of using urinary LTE4 concentrations as predictors of asthma control and markers of susceptibility to treatment with leukotriene receptor antagonists.
Hughes M, Kuiper G, Hoskovec L, WeMott S, Young B, Benka-Coker W Environ Res Health. 2024; 2(3):035007.
PMID: 38962451 PMC: 11220826. DOI: 10.1088/2752-5309/ad52ba.
Wachsmann-Maga A, Maga M, Polczyk R, Wlodarczyk A, Pasieka P, Terlecki K J Clin Med. 2023; 12(10).
PMID: 37240517 PMC: 10219135. DOI: 10.3390/jcm12103412.
Terranova L, Rise P, Gramegna A, Pinna C, Agostoni C, Syren M Respir Res. 2022; 23(1):363.
PMID: 36539829 PMC: 9764713. DOI: 10.1186/s12931-022-02301-5.
Role of biomarkers in understanding and treating children with asthma: towards personalized care.
Lang J, Blake K Pharmgenomics Pers Med. 2013; 6:73-84.
PMID: 24019751 PMC: 3760446. DOI: 10.2147/PGPM.S30626.
Lexmond W, Pardo M, Rooney K, Goettel J, Snapper S, Yen E Clin Exp Allergy. 2013; 43(8):902-13.
PMID: 23889244 PMC: 3728707. DOI: 10.1111/cea.12146.